Nefazodone is known as a selective receptor antagonist. In the current study, it was well tolerated and provided significant early relief of insomnia compared to psychotherapy alone, according to the researchers. The next step is to translate the acute phase findings into appropriate treatment guidelines for initial management of chronic depression. The highest rates of depression occur among adults ages 25-44. In any six-month period, 6.6 percent of women and 3.5 percent will have depressive disorder.
Women are at higher risk for the depression than men.
Factors contributing to the global level of disability associated with depression are high prevalence, increased rates of recurrence, chronicity and associated medical and psychiatry comorbidity. Chronic depression is an episode of major depression that persists more than two years. Chronic depression is a debilitating and often life-threatening disorder. Achieving recovery and preventing relapse or recurrence are essential for the long-term well being of the depressed patient. Studies show that depression treatment requires long-term, skillful followup and active use of antidepressant medication.